Literature DB >> 10235430

Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease.

H P Kohler1, T S Futers, P J Grant.   

Abstract

Activated blood coagulation factor XIII has an important role in the final stage of the clotting cascade by the covalent crosslinking of alpha- and gamma-fibrin chains. We have recently shown that a functional polymorphism in exon 2. codon 34 of the FXIII A-subunit gene is protective against myocardial infarction. To investigate the prevalence of three other common point mutations in the A-subunit gene (codon 564, C to T, 650 G to A and 651 G to C) and their association with FXIII activity and antigen levels, 275 patients with coronary artery disease and 196 controls were studied. There was no difference in the prevalence of the polymorphisms between patients and controls or between patients with or without MI. Only genotype at codon 564 was associated with FXIII activity with lower activities in subjects possessing the T allele. There was evidence of linkage disequilibrium between codon 34 and codon 564. These results suggest that FXIIIVal34Leu is the only common polymorphism in the coding region of the A-subunit gene of FXIII associated with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10235430

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  Genetics of atherosclerosis: the search for genes acting at the level of the vessel wall.

Authors:  V Villa-Colinayo; W Shi; J Araujo; A J Lusis
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

2.  Variants associated with common disease are not unusually differentiated in frequency across populations.

Authors:  Kirk E Lohmueller; Matthew M Mauney; David Reich; John M Braverman
Journal:  Am J Hum Genet       Date:  2005-11-16       Impact factor: 11.025

Review 3.  The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review.

Authors:  Ilona Kopyta; Beata Sarecka-Hujar; Joanna Sordyl; Ryszard Sordyl
Journal:  Mol Biol Rep       Date:  2014-03-01       Impact factor: 2.316

4.  The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model.

Authors:  Florian M Kovar; Claudia L Marsik; Bernd Jilma; Christine Mannhalter; Christian Joukhadar; Oswald F Wagner; Georg Endler
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study.

Authors:  Anke-Hilse Maitland-van der Zee; Bas J M Peters; Amy I Lynch; Eric Boerwinkle; Donna K Arnett; Suzanne Cheng; Barry R Davis; Catherine Leiendecker-Foster; Charles E Ford; John H Eckfeldt
Journal:  Pharmacogenet Genomics       Date:  2009-05       Impact factor: 2.089

6.  Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss.

Authors:  Raheleh Torabi; Saeed Zarei; Hojjat Zeraati; Amir Hassan Zarnani; Mohammad Mehdi Akhondi; Reza Hadavi; Elham Savadi Shiraz; Mahmood Jeddi-Tehrani
Journal:  J Reprod Infertil       Date:  2012-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.